These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29355977)

  • 1. Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy.
    Nishizuka SS; Tamura G; Nakatochi M; Fukushima N; Ohmori Y; Sumida C; Iwaya T; Takahashi T; Koeda K;
    J Surg Oncol; 2018 Apr; 117(5):947-956. PubMed ID: 29355977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection.
    Kang SY; Han JH; Ahn MS; Lee HW; Jeong SH; Park JS; Cho YK; Han SU; Kim YB; Kim JH; Sheen SS; Lim HY; Choi JH
    Int J Cancer; 2012 Feb; 130(4):948-58. PubMed ID: 21425257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.
    Ito S; Ohashi Y; Sasako M
    BMC Cancer; 2018 Apr; 18(1):449. PubMed ID: 29678146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy.
    Omura T; Shimada Y; Nagata T; Okumura T; Fukuoka J; Yamagishi F; Tajika S; Nakajima S; Kawabe A; Tsukada K
    Oncol Rep; 2014 Feb; 31(2):613-8. PubMed ID: 24317477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
    Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
    N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
    Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
    Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer.
    Jeong JH; Park SR; Ahn Y; Ryu MH; Ryoo BY; Kong SY; Yook JH; Yoo MW; Kim BS; Kim BS; Kang YK
    Gastric Cancer; 2017 Jan; 20(1):146-155. PubMed ID: 26715117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer.
    Mori M; Shuto K; Kosugi C; Narushima K; Hayashi H; Matsubara H; Koda K
    BMC Cancer; 2018 Dec; 18(1):1261. PubMed ID: 30558575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.
    Aoyama T; Sato T; Maezawa Y; Kano K; Hayashi T; Yamada T; Yukawa N; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Int J Clin Oncol; 2017 Jun; 22(3):476-483. PubMed ID: 28176023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer patients with Helicobacter pylori infection have a poor prognosis.
    Li G; Wang Z; Wang Z; Xu J; Cui J; Cai S; Zhan W; He Y
    J Surg Oncol; 2013 Dec; 108(7):421-6. PubMed ID: 24037736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer.
    Yamamoto M; Sakaguchi Y; Kinjo N; Yamaguchi S; Egashira A; Minami K; Ikeda Y; Morita M; Toh Y; Okamura T
    Ann Surg Oncol; 2016 Feb; 23(2):546-51. PubMed ID: 26442923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is It a Protective Factor of Helicobacter pylori Infection in Overall Survival of All Gastric Cancer? Evidence from Meta-Analysis.
    Zheng F; Sun Z; Kan J; Yin J; Du F; Shen G; Wang Z; Ren D; Bao X; Zhao J
    J Environ Pathol Toxicol Oncol; 2017; 36(4):309-320. PubMed ID: 29431063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy.
    Wada T; Kunisaki C; Hasegawa S; Takagawa R; Momiyama M; Kosaka T; Makino H; Ono HA; Oshima T; Akiyama H; Endo I
    Anticancer Res; 2013 Apr; 33(4):1747-51. PubMed ID: 23564827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer.
    Miyatani K; Saito H; Shimizu S; Kono Y; Murakami Y; Shishido Y; Matsunaga T; Fukumoto Y; Fujiwara Y
    Int J Clin Oncol; 2019 Oct; 24(10):1190-1196. PubMed ID: 31104175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Impact of adjuvant chemotherapy in patients with T1N2/3 Gastric cancer].
    Tsuchida K; Kunisaki C; Watanabe T; Ono H; Oshima T; Fukushima T; Yoshikawa T; Rino Y; Imada T; Masuda M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2239-41. PubMed ID: 25731482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of S-1 Adjuvant Chemotherapy for Resected Biliary Tract Cancer: A Retrospective Propensity-Matched Analysis.
    Yoshida M; Yanagimoto H; Tsugawa D; Akita M; Urade T; Nanno Y; Fukushima K; Gon H; Komatsu S; Asari S; Kido M; Toyama H; Ajiki T; Fukumoto T
    Am Surg; 2024 Jun; 90(6):1279-1289. PubMed ID: 38226586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of adjuvant chemotherapy with S-1 for gastric cancer patients].
    Kitagawa M; Ichikawa D; Okamoto K; Shiozaki A; Fujiwara H; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1917-9. PubMed ID: 20948256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma.
    Postlewait LM; Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Swords D; Jin LX; Cho CS; Winslow ER; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2016 Apr; 23(4):1225-33. PubMed ID: 26553442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of the human epidermal growth factor receptor 2( HER2) in patients with recurrent gastric cancer who received S-1 adjuvant chemotherapy].
    Aoyama T; Hayashi T; Fujikawa H; Ogata T; Cho H; Wada H; Kitani Y; Yukawa N; Oshima T; Rino Y; Ozawa Y; Masuda M; Yoshikawa T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1647-9. PubMed ID: 24393876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.